Overview

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE DM)

Status:
Not yet recruiting

Trial end date:
2027-12-30

Target enrollment:

Participant gender:

Summary

A multicenter, prospective randomized study evaluating the impact of low-intensity statin plus ezetimibe versus high-intensity statin therapy on risk of new-onset diabetes mellitus in patients with atherosclerotic cardiovascular disease who have prediabetes.

Phase:

N/A

Details

Lead Sponsor:

CardioVascular Research Foundation, Korea

Collaborator:

Yuhan Corporation

Treatments:

Ezetimibe
Hydroxymethylglutaryl-CoA Reductase Inhibitors